Why is a spacer (valved holding chamber) needed for children using a metered‑dose inhaler?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Why Children Need Spacers with Metered-Dose Inhalers

Children require spacers (valved holding chambers) with metered-dose inhalers because they cannot coordinate the timing of inhaler actuation with inhalation, and children under 4 years old cannot generate sufficient inspiratory flow to use MDIs or dry powder inhalers effectively 1.

Primary Reasons for Spacer Use in Children

Coordination Problems

Young children and those under 4 years old have fundamental developmental limitations that make proper MDI technique impossible:

  • Inability to coordinate actuation with inhalation: The standard MDI requires precise timing—actuating the device during a slow, deep inhalation. This coordination is extremely difficult for young children and elderly patients 1.
  • Insufficient inspiratory flow: Most children under 4 years cannot generate the 60 L/min flow needed for dry powder inhalers, making spacers with MDIs the only viable option 1.

Improved Drug Delivery

Spacers fundamentally change how medication reaches the lungs:

  • VHCs improve lung delivery and clinical response in patients with poor MDI technique 1.
  • Without a spacer, 50-80% of the actuated dose deposits in the oropharynx (mouth and throat) rather than reaching the lungs 1.
  • Spacers increase fine particle delivery to the lungs while decreasing wasteful oropharyngeal deposition 2.

Reduced Side Effects

This is particularly important for inhaled corticosteroids:

  • Spacers decrease oropharyngeal deposition, reducing the risk of local side effects like thrush (oral candidiasis), throat irritation, and dysphonia 1, 2.
  • They reduce systemic absorption of drugs with high oral bioavailability, lowering systemic side effects 1.

Age-Specific Recommendations

Children Under 4 Years Old

  • Must use VHC with face mask 1
  • Face mask should have a tight fit
  • Allow 3-5 inhalations per actuation
  • Important caveat: Face mask use reduces lung delivery by 50% compared to mouthpiece, but this is still superior to no delivery at all 1

Children 2-4 Years Old

  • VHC with mouthpiece is preferred if the child can cooperate 1
  • Slow inhalation (30 L/min or 3-5 seconds) followed by 10-second breath-hold
  • Actuate only once into spacer per inhalation

Critical Technical Points

Proper technique matters significantly:

  • Actuate only once into the spacer per inhalation—multiple actuations reduce delivery 1
  • Use slow, deep inhalation (not rapid) when using spacers
  • Clean plastic VHCs monthly with dilute household detergent (1:5000 dilution) and let drip dry to reduce electrostatic charge that can trap medication 1

Clinical Equivalence

Spacers with MDIs are as effective as nebulizers for delivering short-acting beta-agonists and anticholinergics in mild to moderate asthma exacerbations 1. This makes them a practical, portable alternative to bulky nebulizer equipment.

Common Pitfall

Do not assume all spacers are interchangeable. The pairing of a specific pMDI with a specific spacer/VHC should be considered a unique delivery system, as performance varies by device design, material, and valve characteristics 2. Switching spacers may result in reduced medication delivery.

Bottom line: For children, especially those under 4 years, spacers are not optional accessories—they are essential medical devices that transform an otherwise unusable delivery system into an effective treatment method 1.

References

Research

Spacers and Valved Holding Chambers-The Risk of Switching to Different Chambers.

The journal of allergy and clinical immunology. In practice, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.